Skip to main content
Log in

Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Trifilio SM, Scheetz MH, Pi J, Mehta J . Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring. Bone Marrow Transplant (e-pub ahead of print 7 December 2009; doi:10.1038/bmt.2009.345).

    Article  PubMed  Google Scholar 

  2. Mori T, Aisa Y, Kato J, Nakamura Y, Ikeda Y, Okamoto S . Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2009; 44: 371–374.

    Article  CAS  Google Scholar 

  3. Vfend (Voriconazole) Package Insert. Pfizer Inc., New York, NY, 2004.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Mori.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mori, T., Kato, J., Yamane, A. et al. Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients. Bone Marrow Transplant 46, 450–451 (2011). https://doi.org/10.1038/bmt.2010.105

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2010.105

  • Springer Nature Limited

Navigation